FEBS Letters · 1997 · 123 citations · 31 references
Life SciencesNeurologyNeuroscienceMolecular NeuroscienceNeurochemistryNeurodegenerationAlzheimer DiseaseAmyloid FormationNeurodegenerative DiseasesNeurodegenerative DisordersProtein AggregationProtein Aggregation DisordersAlzheimer Disease ProgressionAmyloid Beta AggregationAmyloid Beta PeptidesAmyloid Beta PlaquesAmyloid Plaque FormationAmyloid PlaquesAmyloid StructureAmyloidogenic Peptides
Water-soluble amyloid beta-peptides (sA beta), ending at residue 42, precede amyloid plaques in Down's syndrome (DS). Here we report that sA beta consists of the full-length A beta(1-42) and peptides truncated and modified by cyclization of the N-terminal glutamates, A beta[3(pE)-42] and A beta[11(pE)-42]. The A beta[3(pE)-42] peptide is the most abundant form of sA beta in Alzheimer's disease (AD) brains. In DS, sA beta[3(pE)-42] concentration increases with age and the peptide becomes a dominant species in the presence of plaques. Both pyroglutamate-modified peptides and the full-length A beta form a stable aggregate that is water soluble. The findings point to a crucial role of the aggregated and modified sA beta in the plaque formation and pathogenesis of AD.
31
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Jie Kang, Hans-Georg Lemaire, Axel Unterbeck et al. · Nature · 1987 · 4.6K citations
Amyloid β-peptide is produced by cultured cells during normal metabolism
Christian Haass, Michael G. Schlossmacher, Albert Y. Hung et al. · Nature · 1992 · 1.9K citations
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Peter Seubert, Carmen Vigo‐Pelfrey, Fred Esch et al. · Nature · 1992 · 1.7K citations